Laboratory Equipment Qualification: A Risk-Based Approach

Laboratory equipment qualification must demonstrate suitability for a defined use. The depth of verification depends on the consequences of malfunction, the functions required and the evidence available. A mixer and a controlled chamber do not automatically need the same test package; however, the mixer’s simplicity alone does not demonstrate low criticality. Within EU GMP, Annex 15 links qualification scope to documented risk assessment. [1,2]

This article concerns support equipment and operating conditions in the QC laboratory: deciding what to test, what to accept from existing data and what to exclude from authorised use. The matrix and case are original GuideGxP material to adapt to the site quality system. They are not an approved protocol or a universal instrument classification.

1. Start with the consequence for laboratory work

Describe the activity before assigning an equipment category: what material it holds or processes, for how long, under which conditions and for which decision. “Sample mixing” leaves important questions unanswered. Is the task resuspending material before a quantitative aliquot is taken, or stirring a reagent for an activity that does not affect the result? The same machine may support uses with different consequences.

Examine four impact pathways: alteration of the sample, failure to perform the operational step, error in the measurement used to control it, and loss or misinterpretation of data. A chamber may maintain a stable displayed value while one load position does not meet the required conditions. An alarm may activate locally without reaching the person who must act. These are different risks requiring different evidence.

ICH Q9(R1) also links formality to uncertainty, importance and complexity. Limited knowledge of a critical function does not justify fewer tests. Document assumptions, existing controls and gaps; do not use an unsupported numerical score as a shortcut to reduce the work. Time or resource constraints do not replace technical justification. [2]

2. Distinguish the activities that generate evidence

Commissioning checks and brings the technical arrangement into service. It can generate useful qualification data if planned and assessed for relevance and reliability; it does not become qualification simply by changing the report title. Qualification connects authorised use to evidence about the configuration, functions and performance required.

Calibration concerns the measurement relationship and associated uncertainty; it does not by itself demonstrate that an entire chamber performs correctly with its load. Maintenance preserves or restores functions and may require subsequent checks. Method validation concerns the analytical procedure: a qualified mixer alone does not establish adequate extraction recovery. Chapter 6 distinguishes qualification, calibration and maintenance records from method records. [3,4]

USP 〈1058〉 is relevant to apparatus and systems used in pharmacopoeial analyses, within the chapter’s defined scope. This article does not automatically assign every laboratory device to analytical categories. The public introduction consulted and the revision briefing do not establish the current complete authorised text: confirm it when your use requires it. AIQ is covered in a separate article. [5]

3. Accept supplier evidence without losing its context

List the approved critical requirements and place the candidate evidence beside each one. For an external report, check equipment identity, configuration, conditions, reference instruments, criteria, results and anomalies. “Test passed” does not reveal whether the laboratory’s intended operating scope is covered.

A factory test may address a requirement without unnecessary repetition when its validity and applicability after transport and installation are justified. A change in load, environment, connections or settings may instead create a local gap. Annex 15 provides for reviewing third-party documentation and supplementing it where necessary. [1]

Assign every gap to an owner with an expected decision: obtain a document, perform a test, clarify a requirement or restrict use. The supplier can perform specialist activities; the site must assess the acceptability of the whole through its quality-system responsibilities. An external signature does not automatically close an unresolved question.

4. Installation: establish what is actually being tested

Installation verification identifies the model, serial number, components, accessories, relevant versions, location and services. For a chamber, also record shelves, probe connections, dedicated access ports and monitoring configuration. For a mixer, identify the support, compatible containers and bench arrangement. The configuration must be reconstructable, rather than merely described as “standard”.

Consider room conditions, space, power supply, cleanability and interactions with other activities. Chapters 3 and 6 require equipment and premises appropriate to the work; good performance on the supplier’s test bench does not remove local conditions. Safety checks remain necessary under the applicable framework, but passing an electrical check does not automatically cover GMP suitability. [3,4]

Collect instructions, relevant drawings, the maintenance plan and the status of measurement references. Before execution, clarify which components need calibration and which need another appropriate check. Do not demand calibration of an element without a metrological function simply to fill a box; verify the function that can affect the work instead.

5. Operation: test the functions that matter

Functional tests must cover controls, ranges and conditions relevant to intended use. Switching the equipment on is insufficient. For a mixer, relevant features may include starting mode, container stability and repeatability of a setting; the exact check depends on how the step is defined in the method. A value on a dial is not necessarily a speed measurement.

For a chamber, consider control, indication, monitoring and alarms as separate functions. An appropriate simulation can verify recognition and handling of an abnormal condition, retaining the input, expected response, observed response and restoration. Choose safe scenarios: do not put material intended for routine use at risk merely to demonstrate an alarm.

Where GMP software or electronic records are involved, define the boundary with computerised-system validation. Hardware evidence does not automatically cover access, configurations, data integrity or restoration. Coordinate the applicable activities so that each group does not assume the other has performed the check. [6]

6. Performance: connect the test arrangement with actual use

Performance verification addresses materials or justified substitutes, loads, containers, operators and representative conditions. A substitute must represent behaviour relevant to the test; visual similarity or equal volume is not always enough. The rationale must explain which risk is being observed and what remains outside the experiment. [1]

For the chamber, assess how quantity, arrangement and access affect the conditions actually available to the sample. Do not confuse displayed temperature, spatial distribution, stability over time and recovery after an event. A single reference probe answers a local question; it does not automatically demonstrate the entire usable volume.

Define criteria, duration, sampling and conditions before testing, with reasons linked to the activity. Do not adopt generic values for temperature, uniformity or the number of repetitions. If a criterion cannot yet be justified, resolve the gap during planning, not after seeing the results. Document excluded uses as well.

7. Original matrix: risk, function, test and evidence

The rows are planning examples, not an identical mandatory list for every item of equipment. For each row adopted, add the site requirement, justified criterion, owner and conclusion. One test can support several requirements only when its coverage is explicit.

8. Simulated case: a mixer and a controlled chamber

A laboratory purchases a mixer for a defined homogenisation step in closed containers and a chamber that maintains conditions necessary for samples. The same standard dossier is proposed for both. Instead, the team starts with two use descriptions, identifying consequences, conditions and available knowledge.

For the mixer, it checks installation, container compatibility, relevant functional controls and the ability to support the intended step. If extraction efficiency affects the result, evidence is coordinated with the method: visible movement alone does not demonstrate analytical recovery. The device is not automatically assigned low criticality.

For the chamber, the probe certificate and a supplier’s empty-chamber test do not answer every question. The laboratory defines the permitted load, usable positions, access arrangements, monitoring and alarm handling, then identifies missing local tests. The objective is not more pages, but demonstration of conditions that the generic dossier does not represent.

No successful results are invented in this case. The final decision depends on the data collected. A new mixing container or a different shelf arrangement subsequently triggers impact assessment: verification may be targeted when previous coverage remains demonstrable, or broader if critical behaviour changes.

9. Deviations, conclusions and release for use

Retain original results, anomalies and changes to the test. Repeating a test does not erase the first outcome. Investigate the cause, assess the impact and justify subsequent action under the procedure. The report must show results against criteria and identify requirements not yet covered. [1]

Release for use must state the configuration, ranges, permitted applications, restrictions and responsibilities for open points. A status label must not conceal an essential limitation from the operator. Where evidence on a critical function is missing, do not treat an administrative note as proof of suitability.

Annex 15 permits progression to the next qualification stage under documented conditions when open points do not significantly affect that stage. This is not general permission for routine GMP use with unresolved critical deviations. Distinguish progression of testing, restricted use and final release, with authorised and justified decisions. [1]

10. Maintain and review the qualified state

Link maintenance, calibration, routine checks, anomalies and changes to the scope already demonstrated. After relocation, ask which conditions may have changed: installation, power supply, environment, arrangement, connections or monitoring. After repair, identify the affected function and potential effects on others before returning the equipment to use.

Review also considers gradual changes and performance history. Where periodic requalification is necessary, Annex 15 requires justified intervals and defined criteria; it does not impose a universal annual frequency. A software change or new load may require assessment before the planned due date. [1]

Update the link between risk and testing with what you have learned. An unexpected failure may challenge initial assumptions; a favourable trend does not automatically authorise broader use. Extension to a new application requires a separate decision and relevant evidence.

Operational conclusion

For each item of equipment, make the chain understandable: intended use, risk, required function, test, result and decision. Reuse reliable evidence when it truly covers the configuration and focus verification on relevant gaps. Qualification’s value lies in clearly identifying the use supported by data and its limits.

Continue in the Laboratory Equipment and Controlled Storage HUB and the article on URS with verifiable requirements if the decision to be demonstrated is not yet sufficiently defined.

Sources and applicability

Sources checked on 30 September 2026. The EU GMP references are those listed for human medicines; other contexts require their own assessment. Annex 15, Chapters 3 and 6, and ICH Q9(R1) were consulted in official PDFs, with the relevant sections read. For USP, only the public 2017 introduction was available; the 2025 briefing is a proposal and is not presented as an effective requirement. No consultation of complete USP clauses is claimed. The matrix and case are original GuideGxP material.

1. European Commission — EU GMP Annex 15, Qualification and Validation. 2015 revision, effective 1 October 2015; principles and sections 1–4, 11.
2. EMA/ICH — Q9(R1), Quality Risk Management. Corr.2 document published in 2025; revision effective 26 July 2023, sections 3 and 5.
3. European Commission — EU GMP Chapter 3, Premises and Equipment. Effective 1 March 2015.
4. European Commission — EU GMP Chapter 6, Quality Control. Effective 1 October 2014.
5. USP 〈1058〉 — Analytical Instrument Qualification. Public introduction, 2017 citation. DOI: 10.31003/USPNF_M1124_01_01.
6. European Commission — EU GMP Annex 11, Computerised Systems. January 2011 revision, for applicable GMP computerised functions.